Soluble TREM2 changes during the clinical course of Alzheimer's disease: A meta-analysis

Neuroscience Letters
Dan LiuHui Zhou

Abstract

Soluble triggering receptor expressed on myeloid cells 2 (sTREM2) is a potential and novel biomarker of neuroinflammation implicated in the onset and progression of Alzheimer's disease (AD). However, previous studies evaluating levels of sTREM2 in different clinical stages of AD have yielded inconsistent results. To clarify the dynamic change of sTREM2 in AD progression, we conducted a meta-analysis of case-control and cohort studies to determine the role of cerebral spinal fluid (CSF) and plasma sTREM2 levels in preclinical AD (pre-AD), mild cognitive impairment (MCI) and AD dementia. We searched PubMed, MEDLINE, EMBASE, the Cochrane Library for English articles and Sinomed, CNKI for Chinese. The associations between sTREM2 levels and AD continuum groups (pre-AD, MCI and AD) were analyzed. We further performed detailed subgroup analysis and meta-regression to detect the sources of heterogeneity. 17 reports comprising 82 patients with pre-AD, 159 with MCI, 598 with AD, as well as 754 controls were included in this analysis. Regarding the sTREM2 levels in CSF, the overall pooled standard mean difference (SMD) revealed significantly elevated sTREM2 levels in the whole AD continuum groups (SMD = 0.48; 95% CI: 0.23, 0.73; P < 0.001...Continue Reading

References

Jul 22, 2009·PLoS Medicine·David MoherUNKNOWN PRISMA Group
Aug 20, 2011·Nature Reviews. Drug Discovery·Eric KarranBart De Strooper
Jan 24, 2012·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Bradley T HymanThomas J Montine
Mar 23, 2012·Journal of Neuropathology and Experimental Neurology·Thomas G BeachWalter Kukull
Apr 17, 2012·Neurobiology of Aging·Joshua D GrillUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Nov 16, 2012·The New England Journal of Medicine·Thorlakur JonssonKari Stefansson
Jul 17, 2013·Neurobiology of Aging·Paola ForaboscoMina Ryten
Sep 5, 2013·Journal of Alzheimer's Disease : JAD·Nan HuLan Tan
Feb 26, 2014·Molecular Neurobiology·Frederic BrosseronMichael T Heneka
Jun 26, 2014·Nature Reviews. Immunology·Michael T HenekaEicke Latz
Jul 6, 2014·Science Translational Medicine·Gernot KleinbergerChristian Haass
Jan 13, 2016·Molecular Neurodegeneration·Amanda HeslegraveHenrik Zetterberg
Jan 13, 2016·Multiple Sclerosis : Clinical and Laboratory Research·Annika ÖhrfeltHenrik Zetterberg
Feb 9, 2016·ACS Chemical Neuroscience·Jason D Ulrich, David M Holtzman
Apr 29, 2016·Alzheimer's Research & Therapy·Kristi HenjumLars N G Nilsson
Jul 18, 2016·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Juan Domingo GispertJosé Luis Molinuevo
Feb 6, 2017·Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring·Juan Domingo GispertJosé Luis Molinuevo
Feb 18, 2017·The Journal of Experimental Medicine·Li ZhongGuojun Bu
Dec 25, 2017·Experimental Gerontology·Aurélie Le PageTamas Fulop

❮ Previous
Next ❯

Citations

Jan 22, 2020·The Journal of Immunology : Official Journal of the American Association of Immunologists·Grace E WeberLynn M Bekris
Mar 14, 2020·Clinical Science·Miroslava KacířováLenka Maletínská
Jul 8, 2020·International Journal of Molecular Sciences·Xavier O ScottJuan Pablo de Rivero Vaccari
Jul 16, 2020·Journal of Personalized Medicine·Chiara VillaRomina Combi
May 20, 2020·Translational Psychiatry·André F CarvalhoNathan Herrmann
Jul 9, 2020·Journal of Neuroinflammation·Jiaolong YangZhentao Zhang
Feb 23, 2019·Journal of Neuroinflammation·Kaja NordengenTormod Fladby
Jul 22, 2019·Cells·Onanong Mee-IntaYu-Min Kuo
Feb 11, 2020·Frontiers in Aging Neuroscience·Li Zhong, Xiao-Fen Chen
Jan 12, 2019·Molecular Neurodegeneration·Marc Suárez-CalvetUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Jan 4, 2020·Therapeutic Advances in Neurological Disorders·Marta Milà-AlomàJosé Luís Molinuevo
Dec 28, 2018·International Journal of Molecular Sciences·Cody M WolfeRadosveta Koldamova
Nov 12, 2019·Frontiers in Aging Neuroscience·Changan Liu, Jun Yu
Feb 14, 2021·Brain Sciences·Donovan A McGrowderRuby Alexander-Lindo
Feb 1, 2021·Mechanisms of Ageing and Development·Qi QinYi Tang
Mar 27, 2021·Frontiers in Molecular Biosciences·Evelyn FerriBeatrice Arosio
Apr 1, 2021·The European Journal of Neuroscience·Sadat ShafiFaheem Hyder Pottoo
Apr 27, 2021·Neurobiology of Aging·Emma L van der EndeHarro Seelaar
May 14, 2021·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·David G Morgan, Michelle M Mielke
Aug 28, 2021·Nature Medicine·Tharick A PascoalPedro Rosa-Neto
Sep 2, 2021·Journal of Neuroinflammation·Hongyoon ChoiUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Sep 14, 2021·Brain : a Journal of Neurology·Hsin-Hsi TsaiChe-Feng Chang

❮ Previous
Next ❯

Related Concepts

Related Feeds

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.